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Group A beta hemolytic streptococci have been shown to produce a number 
of  extracellular  products  with  widely  varying  biological  activities  (1).  The 
relationship  between infection by  Group A  streptococci and  the subsequent 
development of either acute rheumatic fever or acute glomerulonephritis has 
stimulated much interest in these products. The fact that most of these prod- 
ucts are antigenic and, following infection in man, result in the development of 
specific neutralizing antibody has formed the basis for several useful strepto- 
coccal antibody tests  (2-4) and for a  number of hypotheses as to the patho- 
genesis of these complications (5, 6). 
Some progress has been made in separation of the extracellular products of 
Group  A  streptococci by zone  electrophoresis and  column  chromatography 
(7-10).  In  this investigation, certain strains  of Group A  streptococci, known 
to  produce  several  extracellular  products,  including  desoxyribonucleases, 
streptolysin O, and streptokinase, were selected for further attempts at sepa- 
ration and purification of these products. 
The present report presents evidence that  there are physical and immuno- 
logical differences between the  streptokinases  produced by certain  Group A 
strains  and  compares  these  Group  A  streptokinases  with  streptokinase  of 
Group C origin. 
Materials and Methods 
Strains of Streptococci.--Strains of Group A streptococci used in electrophoretic,  chroma- 
tographic, and immunologic  studies are as follows: 
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Strain C-203 possesses a Type 3 M antigen and a Type 1 T antigen. This strain was kindly 
furnished by Dr. Rebecca Lancefield. 
Strain 2184 is a  Type 12 streptococcus,  isolated from a  patient with acute nephritis by 
Dr. Floyd Denny. 
Strain H-I05 is a variant of the CO strain of Til]ett which was used for some of the original 
studies on streptokinase (11). It is an undesignated new type. 
Strain 3539 is a Type 1 streptococcus, found to produce high yields of streptokinase. This 
strain was isolated from a patient at the University of Minnesota. 
The following strains of Group A streptococci were employed in electroiShorefic studies only: 
Strain 4784 or A 236  (small colony) was isolated from a mouse epizootic as described by 
Bell eta/. (12) and obtained from Dr. Rebecca Lancefield. 
Strain 2465 or 49 is a Type 12 tetracycline-resistant strain obtained from Dr. W. J. Mogab- 
gab. 
Strain 2501 or 1 GL 88 is a Type 17 streptococcus, isolated at Great Lakes Naval Statioa 
from a  patient with scarlet fever who subsequently developed acute rheumatic fever. This 
strain was obtained from Dr. Rebecca Lancefield. 
Group  A  strains  of streptococci used  in immunologic studies  only included six Type  i 
strains, several Type 4 and Type 12 strains, and single strains of Type 3, Type 25, Type 28, 
and Type 49, all taken from stock strains among the collection in this laboratory. 
A single strain of Group C  streptococcus, strain H-46A, was used in electrophoretic and 
immunologic studies. This is the Group C strain used by Tillett (13) and by Christensen (14) 
for streptokinase studies and also used for commercial preparation of this extracellular product. 
Preparation of Concentrates of Extracellular Products,--Strains  of streptococci were grown 
in a  dialysate medium of Pfanstiehl peptone,  R.I., casamino acids,  and beef heart infusion 
(8).  Concentrates  of the extracelluiar products  in the supematant  fluid were prepared  by 
precipitation with ammonium sulfate, filtration of the suspension through starch  to collect 
the precipitate, and washing of the starch pad with giycine buffer to elute the precipitated 
protein for further concentration by filtration through a collodion bag (8). This technique was 
modified when it was found that higher yields of streptokinase are obtained if the filtered 
supernatant  is refiltered through another starch pad after standing an additional 24 hours. 
The washings from this pad are then combined with the original eluate for concentration in 
collodion bags. 
Electroplwresis.--Extracellular concentrates were examined by starch zone electrophoresis 
according to the method of Kunkel and Slater (15). Glycine buffer, #  =  0.1, pH 9.0, was used. 
A direct current with a  potential difference of 400 v was  applied for  16  hours  at  4°C.  The 
protein was eluted from 1 cm sections of the starch block by washing with 2.0 ml of glycine 
buffer. 
Column Chromatograpky.--Extracellular concentrates were separated by column chroma- 
tography with diethylaminoethyl cellulose (DEAE cellulose)  as the ion exchange material. 
Selectacel, standard DEAE cellulose, lot 1326, obtained from Carl Schleicher and Schuell Co., 
Keene, New Hampshire, was used throughout these experiments. This material has a capacity 
in meq/gm of 0.87. The cellulose was prepared for use by the methods described by Peterson 
and Sober (16). Glydne buffer,/z =  0.01, pH 9.0, was used as the final wash and suspending 
buffer in preparation of the cellulose.  A 30 cm glass  column, with a  1.0 cm inside diameter 
was used, and the cellulose was packed to a height of 15 era. The proteins were separated by 
salt gradient elution. The starting buffer was glycine,/z =  0.01, pPI 9.0,  and the second flask 
contained 1.0 ~  NaC1 in the same glycine buffer. Flat bottom beakers containing 240 ml of 
the appropriate solution were employed to insure a linear gradient. An average of four frac- 
tions per hour, containing 2 ml each, were collected in each experiment. 
Protein  Determinations.--Protein  was  determined  in  the  electrophoretic  and  chroma- 
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Desoxyribonudease Determinations.--Desoxyribonuclease  (DNAse) activity was  measured 
by an adaptation of the alcohol precipitation test (8, 18). The DNAse's utilized as markers in 
this study were identified immunologically by employing specific  neutralizing antisera in a 
modification of the McCarty alcohol precipitation test (9, 18). 
Streptokinase Determinations.--Streptoldnase  determinations were done by a  modification 
of the method of Kaplan (19).  Streptokinase dilutions were made in phosphate buffer, 0.1 M, 
pH  7.4, containing 0.5  per  cent  gelatin,  prepared  according to  the method  described  by 
Christensen (14). The substmte solution used in streptokinase assays was a 0.4 per cent solu- 
tion of fraction II, human plasma (human fibrinogen, parogen, prepared by Cutter Hospital 
Products,  Berkeley, California). Two lots, G 4005 and  G 3911, were used for these studies. 
Substrate  dilutions  were  made  with  buffered  saline.  For  as~ying  streptokinase  activity, 
0.1 ml aliquots of starch block fractions or column eluates were placed in a  10 x 75 mm test 
tube. To each tube 0.5 ml of substrate solution was added, and the mixture was clotted with 
0.1 ml of thrombin solution (Parke,  Davis and Co., Detroit) containing 10 units of bovine 
thrombin/ml. The clots were incubated for 30 minutes in a 37°C water-bath. The end-point 
was read as the highest dilution resulting in complete lysis of the standard clot. 
Commercial Preparations  of Streptokinase.--Varidase  (lot  2200-968-A)  is  a  commercial 
preparation  prepared  by  Lederle  Laboratories,  Pearl  River,  New  York,  containing  both 
streptokinase and streptodoruase, of Group C streptococcal origin. Kinalysin (lot C1914)  is a 
relatively purified preparation of Group C origin, prepared and kindly furnished by Merck, 
Sharp and Dohme Drug Co., West Point, Pennsylvania. 
Examination  of Streptokinase Preparations/or  Froteolyti~ Activily.--Streptokinase-contain- 
ing fractions prepared in this laboratory and the commercial streptokinases were examined 
for their ability to lyse bovine fibrinogen clots. A single lot of Armour bovine fibrinogen,  lot 
55-127,  96.5  per cent clottable after further purification by Laki's method (20),  kindly fur- 
nished by Dr. R. Von Korff, was used in these experiments. The test solutions of streptoldnase 
were first standardized by determining their ability to lyse a standard human fibrinogen clot. 
Various concentrations of the streptokinase solutions were then employed, up to 1000-fold 
over the amount required to lyse a standard h,rn~n fibrinogen clot. Two-tenths ml of a known 
solution of streptokinase was incorporated into a  bovine fibrin clot, containing 0.5 ml of a 
0.6 per cent fibrinogen solution clotted with 0.1 ml thrombin. Incubation was carried out in a 
water-bath at 37°C.  Observations were made at hourly intervals for 8 hours and clots were 
allowed to stand in the water-bath overnight for observations after 24 hours of incubation. 
The streptokinase preparations were also examined for evidence of proteolytie activity on 
heated and unheated bovine fibrin plates prepared by the method of Astrup and MuUertz (21) 
and kindly furnished by Dr. Henry Gans. In this experiment 0.05 ml of varying concentrations 
of the streptokinases under study were spotted on plates cont~in~ngheated or unheated bovine 
fibrin  and  then  were  incubated  18  hours  at  37°C.  Control-heated  plates  were  run  si- 
multaneously, in which human plasminogen had been added  to the test spots.  The human 
plasminogen was prepared in Dr.  Gans' laboratory from plasma fraction IH, furnished by 
E. R. Squibb and Sons, New York. 
Studies of tke Effect of pH and Temperature on the Stability of Streptokinase.--These  experi- 
ments were done by a modification of the methods described by Christensen (22). The strepto- 
kinase solutions were incubated at 56°C for 1 hour in buffers of the appropriate pH. Acetate 
buffer was used for determlning the effect of pI-I 5.1 and 5.5 and glycine buffer for pH 9.5. For 
assaying  residual  streptokinase  activity,  dilutions were  made  in  pbosphate-gelatin  buffer, 
pH 7.6. 
Inttibition of Plasminogen Activation by Epsilon Arainocaproic Acid (EACA).--The strepto- 
kinases being compared in these experiments were standardized  as in the antibody studies. 
To  insure  streptokinase  excess,  the  concentration  of streptokinase  used  in  the  inhibition 
studies was twice the concentration resulting in complete clot lysis in 30 minutes. The stock 354  DIFFERENCES AMONG STREPTOKINASES 
solution of epsilon aminocaproic acid  (EACA) contained 20 mg/ml.  Serial 2-fold dilutions 
were made from this stock solution. Strcptokinase, 0.2 ml, and EACA dilutions, 0.1 ml, were 
mixed and allowed to stand at room temperature for 15 minutes. Then fibrinogen was added, 
and the clot was formed by addition of thrombin. Results were recorded as the minimal con- 
centration of EACA resulting in complete inhibition  of clot lysis by the various streptokinases 
being tested. 
Preparation of Specific Rabbit Antisera.--Rabbits were immunized with streptokinase frac- 
tions from Group A strains prepared by starch block electrophoresis or by column chroma- 
tography. Commercial varidase or kinaiysin was used as a source of streptokinase of Group C 
origin for immunization. An emulsion was prepared containing two parts antigen solution, 
two parts heavy mineral off, and one part aquaphor. The mixture was allowed to cool and 
was injected subcutaneously in 2 ml volumes. Injections were given twice weekly. After the 
1st month the animals were rested for a period of 4 weeks, and injections were then continued 
for a total of at least 2 additional months. 
Streptokinase Antibody  Determinations.--These  determinations were done by a  modifica- 
tion of the method of Kaplan (19). Streptokinase from Group A strains used in antibody 
determinations consisted of partially purified fractions prepared by either starch block electro- 
phoresis or column chromatography techniques. In some instances, lyophilized preparations 
were redissolved in buffer and in other instances freshly prepared antigens were employed. 
The streptokinase of Group C origin used in antibody assays was either varidase or kinaiysin, 
both of which are commercial preparations. Gelatin buffer, as prepared for the streptokinase 
assay was used in making streptokinase dilutions. For most of the antibody determinations, 
Cutter human fibrinogen, lot  G 4005 was used. However, when a second lot, G 3911, was 
employed, using known antisera as controls, no significant differences in titers were obtained. 
Immunode~trophoresis.--Microslide  immunoelectrophoresis was  done  by  methods  de- 
scribed by Crowle (23). Agar-agar, (Baltimore Biological  Laboratories, Baltimore, lot 111623) 
1.5 per cent, was used in preparing slides. A barbital buffer, t~ ~  0.1, pH 8.2, was employed. 
Electrophoresis was conducted at 4°C for 1 hour with a potential difference of 60 v. Photo- 
graphs were taken of unstained slides. 
Antistreptolysin  0  Determlnations.--These  determinations  were done by the  method of 
Rantz and Randall  (24). 
I~ESULTS 
A  difference in the mobilities of the streptokinases from different Group A 
strains  was  initially suggested  when  individual electrophoretic  patterns  of 
extracellular products from strains 2184  and C-203 were examined. The pro- 
duction of similar desoxyribonucleases (DNAse's) by these two strains made 
it possible to utilize these enzymes as markers in comparing the mobilities of 
the  streptokinases.  The DNAse D  of  strain 2184 was  observed  to  have  the 
same mobility as that of strain C-203, and this enzyme was of particular value 
as a  marker. Under the conditions of this study, the peak activity of DNAse 
D  of strain C-203 coincided with the peak activity of streptokinase produced by 
that strain, but the streptokinase of strain 2184 migrated further towards the 
anode. 
In order to exclude the possibility that minor variations in physical condi- 
tions of  individual experiments might result in these  differences in mobility 
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strains were separated in parallel  starch blocks in the same  experiment  and 
artificial mixtures of the extracellular  products from the two strains were also 
examined by electrophoresis. The results of the parallel starch block experiment 
are shown in Fig.  1. The upper portion of the graph illustrates the electro- 
phoretic  distribution of the streptokinase and desoxyribonucleases  of strain 
2184. The lower section of the graph represents  the pattern obtained with the 
extracellular concentrate of strain C-203. It can be seen that the peak activities 
of DNAse B and DNAse D of these two strains are located in the same zones 
of their respective  starch blocks. Strain C-203 is also observed  to produce  a 
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Fig. 1.  Comparison of the distribution of extracellular products of strain 2184 and strain 
C-203 by parallel zone electrophoresis.  (SK, streptokinase, DNAse, desoxyribonuclease.) 
small  quantity of DNAse  C.  The  streptokinase of strain  C-203 shares  the 
same zone as DNAse D  of that strain, while the streptokinase of strain 2184 
has migrated more towards the anode, and its peak is separated by about 5 cm 
from the peak of the DNAse D activity. 
Resolution of an artificial mixture of the extraceUular concentrates of these 
two strains by zone electrophoresis is illustrated in Fig. 2. In this experiment, 
streptokinase activity resolved into two distinct peaks  separated by approxi- 
mately 9  cm.  Desoxyribonuclease  peaks  were  typical in  distribution.  The 
streptokinase peak nearest the point of origin coincided with the DNAse D 
peak of this mixture and was compatible with the previously observed mobility 
of  streptokinase  of strain  C-203. The  second  streptokinase peak  was  more 
anodal in its mobility and was well separated from the DNAse D peak as was 356  DLFI~EILENCF.S AMONG STREPTOKINASES 
previously observed with the streptokinase of strain 2184. As will be subse- 
quently shown, the two streptokinase peaks could be identified serologically as 
representing the streptokinases of strains C-203 and 2184 respectively. 
Evidence  of physical differences between  the  streptokinases  of  these  two 
strains was also obtained by column chromatography. Salt gradient elution 
from a  diethylaminoethyl cellulose  (DEAE  cellulose)  column produced  ex- 
cellent separation of the DNAse's~ and these again proved to be useful markers 
in  comparing the  streptokinases  of  these  two  strains.  In  individual experi- 
ments, performed under the same conditions, the streptokinase of strain C-203 
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Fig.  2.  Resolution by zone  electrophoresis of an  artificial mixture  of  the  extracellular 
products  of strains  2184  and  C-203.  (SK,  streptokinase,  DNAse, desoxyribonuclease.) 
was eluted in the same fractions as the DNAse  D  of this strain,  while the 
streptokinase of strain 2184 was eluted at a higher salt concentration than the 
DNAse D  of that strain. When a mixture of the extracellular products from 
these two strains was applied to a DEAE cellulose column, excellent resolution 
of the two streptokinases was obtained (Fig. 3). The first streptokinase peak 
to be eluted was identified in the same fractions as the DNAse D of this mixture 
and thus appeared to correspond with the streptokinase peak obtained when 
strain C-203 was chromatographed separately. The second streptokinase peak 
was well separated from DNAse D  activity and was eluted at a  salt concen- 
tration comparable to that of strain 2184 streptokinase. Subsequent serologic 
examination of the  two streptokinase peaks  identified them as  the strepto- 
kinases of strains C-203 and 2184, respectively. Similar elution patterns were HUGH  C.  DILLON AND  LEWIS  W.  WANNAMAKER  357 
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Fig. 3.  Resolution by column chromatography of an artificial mixture of the extra.cellular 
products of strains 2184 and C-203. (SK, streptokinase, DNAse, desoxyribonuclease.) 
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obtained on rechromatography.  Fig. 4 illustrates  the results of rechromatog- 
raphy of the streptokinase from the second peak shown in Fig. 3,  the peak 
corresponding  to  the  streptokinase  of strain  2184. On rechromatography,  a 
single peak of streptokinase activity was obtained and this was eluted at the 358  DIFFERENCES  AMONG  STREPTOKINASES 
same salt concentration as in the original mixture. The streptokinase obtained 
in this peak was subsequently shown to be immunologically like that of strain 
2184 streptokinase. 
Although the culture conditions employed do not favor proteinase produc- 
tion,  the  possibility  that  one  of  these  activities might  represent proteinase 
rather  than  streptokinase  activity  was  considered.  This  possibility  was  ex- 
amined by determining the ability of these materials to lyse bovine fibrinogen 
clots, which  are susceptible to the former but not to the latter product.  No 
clot lysis  occurred with  any of the streptokinase preparations being investi- 
gated, even though concentrations up to 1000-fold over the amount required 
to lyse a standard human fibrinogen clot were employed and observations were 
continued over a 24 hour period. 
TABLE  I 
Immunological Comparison of Streptokina3es from Two Group A  Strains:  Neutralizing  Titers 
with Homologous and Haerologous Antisera 
Antigens 
2184 SK (SK-A)*  ................................... 
C-203 SK(SK-B)~ .................................. 
No. of tubes difference  intiter ........................ 
Antisera 
Anti-2184 SK 
1:417 
1:83 
4 
Anti-C-203 SK 
1:83 
1:417 
4 
* Streptokinase from strain 2184, subsequently referred to as SK-A. 
Streptokinase from strain C-203, subsequently referred to as SK-B. 
Similarly, evidence for proteolytic activity was sought by testing the strepto- 
kinases for their ability to lyse heated and unheated bovine fibrin plates. No 
proteolysis occurred on either the heated or unheated plates. With the addi- 
tion of a  preparation of human plasminogen to the heated fibrin plates,  all 
of the streptokinase preparations produced definite proteolysis. With a constant 
amount of plasminogen the extent of the proteolysis was related to the con- 
centration  of streptokinase employed. These findings  indicated  that  the  in- 
dividual peaks obtained on electrophoresis and column chromatography were 
due to activation of plasminogen and not to proteinase activity. 
Upon the demonstration of distinct physical differences in the streptokinases 
of the two strains, 2184 and C-203,  the possibility of immunological differences 
in  the  streptokinases  from  these  two  strains  was  investigated.  Lyophilized 
fractions of streptokinase from strains  2184 and  C-203,  obtained by electro- 
phoretic or chromatographic separations, were used to immunize rabbits. The 
differences in titer obtained when antisera to the streptokinase of strains 2184 
and C-203  were examined with the homologous and heterologous antigen are 
presented in Table I.  Although some degree of cross-reaction was  observed, HUGH  C.  DILLON  AND  LEWIS  W.  WANNAMAKER  359 
significantly higher  titers  were obtained with  the homologous systems, sug- 
gesting  at  least  partial  antigenic  specificity.  These  findings  were consistent 
with all preparations of antigen and antisera examined,  although serum from 
earlier  bleedings  during  the  course  of  immunization  usually  showed lower 
titers and less cross-reactivity. These antisera were sufficiently  specific to be 
useful in immunological  identification of the individual peaks of streptokinase 
obtained by electrophoresis or by column chromatography.  For convenience 
of discussion,  the streptoldnase  of strain  2184 is subsequently referred to as 
SK-A and that of strain C-203 as SK-B. 
A comparison was made of the physical and immunological properties of these 
streptokinases  with  those  obtained  from  other  sources.  The  streptokinase 
produced by another Group A strain, H-105, was shown to be similar to SK-A. 
Both the electrophoretic distribution and the chromatographic elution of this 
streptokinase were quite similar  to those patterns characteristic of SK-A. Im- 
munological studies, utilizing  H-105 streptokinase and specific antisera to this 
material,  in comparison with  the antigens  and  antisera  of SK-A and  SK-B, 
indicated that the streptokinase of strain H-105 was also immunologically like 
that of SK-A. 
The electrophoretic mobility of the streptokinases of Group A strains 2501, 
2465, and 4784 was found to be similar  to that of SK-A. Immunologic studies 
have not been done with the streptokinases of these strains. 
The streptokinase of a Type 1 strain, 3539, an unusually good producer of 
streptokinase, was found to be electrophoreticaUy and immunologically similar 
to that of strain  C-203 (SK-B). As with the latter strain, when a concentrate 
of the extracellular products of strain 3539 was mixed with a concentrate from 
strain 2184, good resolution of the streptokinases of these two strains was ob- 
tained  by column  chromatography.  Antisera  to  SK-A and  SK-B  were em- 
ployed in confirming  the immunological  identities  of the  two peaks.  Better 
separation of streptokinase and DNAse D  was obtained by chromatography 
of extracellular  preparations  of strain  3539  than  with preparations  of strain 
C-203, apparently due to elution of the streptokinase of the former strain at a 
slightly lower salt concentration. 
Antisera to SK-A and SK-B have been employed in the screening  of crude 
supernates of a  number of Group A strains of streptococci, other than those 
strains examined by electrophoresis or chromatography. The strains examined 
included six Type 1 streptococci, several strains of Type 12 and Type 4 strepto- 
cocci, and single strains  of Type 3, Type 25, Type 28, and Type 49 strepto- 
cocci. Neutralization patterns of the Type 1 and Type 3 strains suggest that 
these strains produce streptokinase immunologieally similar  to that  of strain 
C-203 (SK-B) while the streptokinase obtained from strains of other types were 
immunologically like that of strain 2184 (SK-A). 
Six human sera,  with elevated antistreptolysin O titers,  were employed in 360  DIFFERENCES AMONG  STREPTOKINASES 
TABLE  II 
Immunological  Comparison of  Group A Slreptokinases:  Neutralizing  Antibody  Tit*rs  in  Human 
Sera Using Two Different Antigens 
Antigens 
SK-A* ............................ 
SK-B~ ............................ 
No. of tubes difference in titer ........ 
AS0 titer§ ......................... 
Patient sera 
......  J.K.  C.N.  S.C.  M.S.  L.F.  C.H. 
1:179  I 1:900  I 1:417  I 1:417  I 1:125  [ 1:25 
<1:25  I 1:9°°11:4171  1:125  1:125  1:36 
s  io  io  13  }o  I1 
1250  1125o  1,25o  1s33  11250 1833 
* SK-A obtained from strain 2184. 
:~ SK-B obtained from strain  C-203. 
§ Antistreptolysin  O  titer  (Todd  units). 
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Fig.  5.  Resolution  by zone  electrophoresis  of an  artificial  mixture of the  extracellular 
products of strain 2184 and a concentrated solution of varidase (Group C SK). (SK, strepto- 
kinase.) 
streptokinase neutralization studies.  A  comparison was made  of the  titers  ob- 
tained when SK-A and SK-B were used as antigens  (Table II). The sera from 
two patients,  J.  K.  and M.  S.,  showed  a  significant  difference when  the  two 
streptokinase antigens were compared. 
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TABLE Ili 
Immunological  Comparison of Streptokinase from a Group A  Strain  (C-203) and Commercial 
Kinalysin (Group C Slreptokinase): Neutralizing Antibody  Titer with 
Homologous and Heterologous Antisera 
Antigens 
C-203  SK (SK-B) .................................. 
Group C streptokinase ............................. 
No. of tubes difference in titer ...................... 
Antisera 
Antikinalysin 
1:83 
1:179 
2 
Anti-C-203 SK 
1:417 
1:56 
5 
TABLE IV 
Immunological  Comparison of Streptokinase from  a  Group A  Strain  (2184) and  Kinalysin 
(Group C Streptokinase) : Neutralizing Antibody  Titer with 
Homologous and Heterologous Antisera 
Antigens 
2184 SK (SK-A) .................................... 
Group C streptokinase ............................. 
No. of tubes difference in titer ....................... 
Antisera 
Anti-2184 SK 
1:417 
1:278 
1 
AntikinMysin 
1:125 
1:179 
I 
TABLE V 
Immunologic Relationships of SK-A, SK-B, and Group C Streptokinase Based on Neutralizing 
Antibody Determinations with Homologous and Heterologous Antisera 
Anti-SK-A 
SK-A ................................. 
SK-B. 
Group C streptokinase .................. 
Anti-SK-B 
Antisera 
Antigen 
417"  83 
83  417 
278  56 
Anti-Group C 
streptokinase 
125 
83 
179 
* Reciprocal of neutralizing antibody  titer. 
streptokinase  of Group C  origin, it was desirable to compare  this material with 
the  Group  A  streptokinases  under  examination.  Studies  were  performed  on 
three  Group  C  preparations;  commercial varidase,  commercial kinalysin,  and 
an  extracellular  concentrate  of  their  source  strain,  H-46A,  prepared  in  this 
laboratory in the same manner as the Group A concentrates. The electrophoretic 
mobility in starch of these Group C  preparations  was found to be identical and 
was intermediate  between that  of SK-A and  SK-B. 362  DIFFERENCES  AMONG  STREPTOKINASES 
FIG.  6.  (a) Immunoelectrophoresis of SK-A (top well) and SK-B (bottom well) with anti- 
SK-A  (serum trench).  Precipitin  line with  homologous antigen  only.  (b)  Immunoelectro- 
phoresis of SK-A (top well) and  Group C streptokinase  (bottom  well) with  anti-Group  C 
streptokinase  (serum trench).  Precipitin  line with  homologous antigen  only.  (c)  Immuno- 
electrophoresis of SK-B (top well) and SK-A (bottom well) with anti-SK-B  (serum trench). 
Precipitin line with homologous antigen only, 
Because  of  the  immunological  similarity  of  the  Group  C  streptokinase  to 
SK-A, subsequently shown, it was important to confirm the physical differences 
between  these  two  streptokinases.  Accordingly,  an  artificial  mixture  of  an 
extracellular  concentrate  of strain  2184  (source  strain  for  SK-A)  and  a  con- 
centrated  solution  of varidase  were  examined  by starch  zone  eleetrophoresis. HUGH  C.  DILLON  AND  LEWIS  W.  WANNAMAKER  363 
Streptokinase activity partially resolved into two distinct peaks separated by 
5 cm, illustrated in Fig. 5. Peak 1 had a mobility characteristic of the strepto- 
kinase of Group C (varidase)  origin, and peak 2 had a mobility characteristic 
of SK-A (strain 2184). 
Both kinalysin and varidase were used in the preparation of antisera to the 
Group C streptokinase and were found to be immunologically  identical.  The 
fiters obtained when antibody to kinalysin and antibody to SK-B (C-203) were 
examined with homologous and heterologous  antigens are illustrated in Table 
III.  Although cross-reactions  were  noted,  there appeared  to be  definite  im- 
munological differences. In Table IV are shown the data comparing SK-A and 
kinalysin. No  definite  immunological  differences  were  found between  these 
two antigens.  Table V summarizes  the immunologic  relationships,  based  on 
TABLE  VI 
Immunological  Rdationships  of Three Streptokinases on Immunodectrophore3is  Using 
Concentrated A ntisera 
Antigens 
SK-A  ................................. 
SK-B ................................ 
Group C  streptokinase ................. 
Anti-SK-A 
+++ 
0 
+ 
Antisera 
Anti-SK-B 
o 
+++ 
+ 
Anti-Group C 
streptokinase 
o 
o 
+++ 
-+-'+--k-, Strong precipitin reaction. 
O, No precipitin reaction. 
-]-, Definite precipitin reaction but weaker than seen with homologous antigen. 
neutralizing antibody determinations, of SK-A, SK-B,  and Group  C strepto- 
kinase. 
Immunoelectrophoresis  has  been  used  as  another  method for  comparing 
SK-A, SK-B, and Group C streptokinase.  The results of these immunoelectro- 
phoretic studies confirm both the physical and immunological  differences in 
these three streptokinases.  The relative migrations of the streptokinases are 
similar to those observed when they are examined by starch zone electrophore- 
sis. SK-A migrates towards the anode,  SK-B moves toward the cathode, and 
the Group  C streptokinase is intermediate between the two Group A strepto- 
kinases. These patterns are illustrated in Fig. 6. The cross-reactions seen in the 
neutralizing antibody studies  do  not  appear  in  the  immunoelectrophoresis 
experiments  illustrated. This may reflect intrinsic differences in precipitating 
and neutralizing antibody to the streptokinases  or may simply be a result of 
the concentrations of antigen and antibody used. The latter possibility is sug- 
gested by the fact that if 4-fold concentrated antisera to either SK-A or SK-B 364  DIFFERENCES  AMONG  STREPTOKINASES 
were employed, a  precipitin line would form with  Group C  streptokinase. On 
the other hand,  even with concentrated antiserum to Group C  streptokinase, 
precipitin lines with SK-A and SK-B did not occur.  Similarly, use of concen- 
trated  antisera did not disclose cross-reactions between  the SK-A and  SK-B 
systems. These results are summarized in Table VI. 
TABLE  VII 
The Effect  of ptt and  Temperature  on Streptokinase  Activity 
Strepto-  Buffer 
kinases 
SK-A  Gelatin 
Gelatin 
Acetate 
Acetate 
Glycine 
SK-B  Gelatin 
Gelatin 
Acetate 
Acetate 
Glycine 
Group  Gelatin 
C SK  Gelatin 
Acetate 
Acetate 
Glycine 
0  0 
0  0 
0  0 
0  0 
0  0 
•  I-  0 
-I-  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
+, clot lysis. 
0, no clot lysis. 
SK, streptokinase. 
The  effect of  temperature  at  various  hydrogen-ion  concentrations  on  the 
stability of SK-A, SK-B and Group C streptokinase was studied  (Table VII). 
No significant difference in the stability of the three streptokinases was found. 
Each  of the  three  streptokinases showed  complete inactivation following in- 
cubation at 56°C. for 1 hour at pH 5.1. There was some loss of activity following 
incubation at pH 9.5, but all retained significant activity. Incubation at 56°C. 
at pH 7.6  did not result in loss of activity. 
These  several  streptokinases  were  also  compared  in  relationship  to  the 
inhibition  of  their  plasminogen-activation  by  epsilon  aminocaproic  acid 
(EACA). The results are shown in Table VIII. These assays were carried out HUGH C.  DILLON AND LEWIS W.  WANNAMAKER  365 
simultaneously,  employing  varying  concentrations  of  EACA  with  constant 
equivalent concentrations of streptokinase.  There were no significant quantita- 
tive  differences  in EACA-inhibition  of plasminogen-activation  by any of the 
streptokinases.  Although  the  use  of this  inhibitor  failed  to demonstrate  any 
additional  differences  in these  streptokinases,  the fact  that  EACA in  the  ex- 
pected  concentrations  did  inhibit  all  of them  was  further  evidence  that  the 
mechanism  of induction  of clot  lysis  by  these  streptokinases  was  the  same, 
namely that of activation of plasminogen rather than direct proteolytic action. 
TABLE VIII 
The Effect of Inhibition  of Plasminogen Activation of Streptokinases by 
Epsilon Aminocaproic A cid 
Streptokinases 
SK-A ........................ 
SK-B ........................ 
Group C ...................... 
Epsilon aminocaproic  acid concentrations (mcg/ml) 
2000  I000  500  250  125  62.5  31.25  15.6 
o  I  o  o  o  ol+l+l+ 
Ol  ol  Ol  o1+1+1+1+ 
o  I  o  /  o  I  o  I  o1+1+1+ 
+, complete clot lysis. 
O, no clot lysis. 
DISCUSSION 
Previous  reports  concerning  the  similarity  or  dissimilarity  among strepto- 
kinases produced by different serologic groups of beta hemolytic streptococci, 
or by various strains of Group A streptococci, have been based on immunologic 
studies employing human sera. The most recent and best quantitated  investi- 
gations are those of Kaplan  (25)  and Weinstein  (26). 
In Kaplan's studies of streptokinases from a Group A, a Group C, and a Group G 
streptococcus, in which sera from patients with infections caused by streptococci of 
the above-mentioned groups were used,  there were no demonstrable  kmmunologica] 
differences  among these three streptokinases.  The sera obtained from patients with 
Group C and Group G infections were of low titer. However, the sera from the Group 
A infections were of good titer, and did not differ in neutralizing titer when the three 
streptokinases  from different serologic  groups were used in antistreptokinase  deter- 
minations.  Kaplan  concluded  that  there  were  no  immunologic  differences  among 
streptokinases. It is probable that the currently accepted use of the commercial Group 
C  streptokinase  as  the antigen  in  antistreptokinase  determinations  is  based  on 
Kaplan's  studies. 
Weinstein,  employing  Kaplan's  methods  for  antistreptokinase  determinations, 
studied the immunologic patterns of streptokinases obtained from 10 different strains 
of Group A streptococci. Using 25 sera obtained from patients with scarlet fever, he 
found that neutralizing  titers  differed significantly when  the various streptokinases 366  DIFFERENCES  AMONG  STREPTOKINASES 
from the 10 different strains were employed as antigens. He concluded that there was a 
definite dissimilarity  in the streptokinases  obtained from different  Group A strains 
and considered  the antistreptokinase test employing  a  single antigen as  unreliable 
for this reason. 
In an earlier study of "antifibrinolysins,"  Mote et al.  (27) found results similar  to 
those of Weinstein.  Although handicapped by methods which were less quantitative 
than Kaplan's, these investigators  found that titers varied when different strains of 
streptococci  were used as the streptokinase  source. This early study of Mote et  al. 
and the later, more quantitative study of Weinstein  thus support the evidence pre- 
sented here that there are immunological differences in streptokinases  obtained from 
different strains of Group A streptococci. 
The present  investigation indicates  that  there are  both physical  and  im- 
munological differences in  the  streptokinases produced by various  Group  A 
strains.  The partial immunological cross-reactions that occurred suggest that 
there  are  antigenic relationships  between  these  streptokinases,  probably re- 
flecting shared antigenic determinants.  The possibility that  these cross-reac- 
tions might represent contamination with small amounts of heterologous antigen 
cannot be excluded. However, this seems unlikely since in the studies  of in- 
dividual strains only single peaks of streptokinase were obtained and artificial 
mixtures of the streptokinases from different strains could be separated  rea- 
sonably well by either starch block electrophoresis or column chromatography. 
In addition, antisera were prepared with the peak fractions of electrophoretic 
or  chromatographically purified  preparations  which  would  tend  to  remove 
small amounts of contaminating antigens which might be undetectable in assay 
procedures. The partial cross-reactions seen between SK-A and SK-B began 
to appear as continued immunization of animals resulted in the development 
of antistreptokinase  titers  of  1:83  or  greater  with  the  homologous antigen. 
In two of the six human sera examined with SK-A and SK-B, definite differ- 
ences in antistreptokinase titer were obtained. In the case of patient J. K., who 
had acute glomerulonephritis, it would appear that the child had had no ex- 
perience with a streptococcus producing SK-B, and had not developed a suffi- 
cient antibody titer to SK-A for cross-reactions with SK-B to become apparent. 
The results  with  this patient's  serum may thus be analogous  to the results 
obtained when antibody titers to SK-A and SK-B were compared in sera from 
early bleedings of immunized animals. 
Examination  of  these  two  streptokinases  by immunoelectrophoretic tech- 
niques confirms the electrophoretic and neutralizing antibody studies indicat- 
ing their differences. Precipitin lines occurred with  the  homologous antigen- 
antibody systems of SK-A and SK-B only and distinct differences in migration 
were apparent. It appears that this may be a useful method of demonstrating 
the immunologic differences that exist between these two streptoldnases since, 
in the concentrations employed, the cross-reactions seen with the neutralizing 
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Of a total of seven strains of Group A streptococci examined electrophoreti- 
cally, five proved to have streptokinases with electrophoretic mobilities similar 
to that of SK-A while  only two, C-203 and 3539, were observed to have the 
electrophoretic pattern characteristic of SK-B. It is of interest that these two 
strains  also  produced  identical  desoxyribonucleases.  The  similarity  of  the 
streptokinases of these strains suggested by electrophoretic studies could also 
be demonstrated immunologically. 
In addition  to those strains  studied by electrophoresis,  the streptokinases 
of a number of strains of various serologic types were examined for their im- 
munologic  relationship to either SK-A or SK-B by utilizing  their crude super- 
nates as antigens in neutralizing  antibody studies. In these studies, only the 
streptokinases from Type 1 and  the Type 3 strains  were found to resemble 
SK-B. The remaining strains, including  several of Type 12, a Type 4, a Type 
25, a Type 28, and a Type 49, were indistinguishable from SK-A. The combined 
data of the electrophoretic and immunological  studies clearly suggest that of 
the two Group A streptokinases represented by the prototype strains,  SK-A 
appears to be the one more commonly encountered among Group A strains. 
There is a possible relationship between serologic type of Group A strepto- 
coccus and production of either SK-A or SK-B. Thus, the only strains examined 
during  this investigation with electrophoretic patterns  typical of SK-B were 
the C-203 strain, a Type 3 streptococcus with a Type 1 T antigen, and 3539, a 
Type  1  streptococcus.  Moreover,  the  only  strains  encountered  during  the 
screening  of crude supernates containing streptokinase activity which were im- 
munologically like SK-B  were several Type 1 strains  and  a  Type 3  strain. 
Earlier studies by the Commission  on Acute Respiratory Diseases (28) demon- 
strated  that  patients  with streptococcal infection due to Type 1 or Type 3 
streptococci had a  generally lower antistreptokinase  titer than patients with 
certain other serologic types. They related the development of antibody forma- 
tion in these patients to the in vitro production of streptokinase by the various 
serologic  types isolated.  Their  studies  indicated  a  difference  in  the  median 
titers of streptokinase produced by various serologic types of streptococci and 
also  demonstrated  that  frequency  of  production  of  streptokinase  could  be 
related to serologic type. It seems possible that some of the differences in anti- 
streptokinase titers in the patients reported by this group might  well be ex- 
plained by differences  in antigenic structure of streptokinases from strains of 
different serologic types. 
Because of its extensive use as a prototype in studies of streptokinase and 
antistreptokinase and because of its use in clinical medicine,  the streptokinase 
obtained from strain H-46A, a  Group C streptococcus, which is the source of 
the  commercial  streptokinases,  is  of particular  interest.  The  electrophoretic 
mobility of this Group C streptokinase was found to be intermediate between 
that  of SK-A and SK-B. Although cross-reactions were observed, neutraliza- 
tion  studies suggest that  there  is  a  definite  quantitative  immunological  dif- 368  DIFFERENCES  AMONG  STREPTOKINASES 
ference  between  Group  C  streptokinase  and  SK-B.  Little or  no  difference 
between  Group C streptokinase  and SK-A was seen in neutralization studies. 
Immunoelectrophoretic studies  revealed  what appears  to be only a  one way 
cross-reaction  between  streptokinase of  Group  C  origin  and both  Group  A 
streptokinases  which was dependent on the use of concentrated antisera to the 
latter. 
The results of the neutralizing antibody studies are not necessarily in conflict 
with Kaplan's findings  of immunologic similarity between streptokinases  of 
Group A and Group C origin, since Kaplan examined the streptokinase of only 
one  Group  A strain, and since there appears  to be little difference immuno- 
logically between one of the Group A streptokinases  studied (SK-A) and the 
commercial Group C streptokinase.  Indeed, since SK-A appears to be the more 
commonly encountered  streptokinase of  Group  A  origin,  the  selection  of a 
single strain of Group A streptococcus for producing streptokinase would likely 
result in choosing a strain which elaborates SK-A. 
The fundamental significance of the differences in streptokinases  produced 
by Group A strains of streptococci and by other serologic groups of streptococi 
is not known, From a practical viewpoint,  it is obvious that these  differences 
may result in the erroneous interpretation of antistreptokinase data, since the 
antigen chosen for use in the antibody determination may differ from that 
produced by the infecting streptococcus. Immunological differences in strepto- 
kinases may also be of importance in regard to fibrinolyfic therapy. Fletcher 
et  al.  (29) have shown  that patients receiving  streptokinase therapeutically 
may develop high antibody titers rather quickly and this may then interfere 
with  streptokinase-activation  of  plasminogen.  Streptokinase  differing  in 
antigenic  structure from that customarily used  in therapy might make pro- 
longed therapy more feasible. 
Differences in the physical and antigenic  characteristics  of streptokinases 
are  also of interest from the standpoint of the biology of the streptococcus. 
The versatility of this organism in producing a variety of extracellular products 
is already well appreciated.  The differences in streptokinases  as represented 
by SK-A, SK-B, and Group C streptokinase have not been clarified beyond the 
fact  that  certain physical  and  immunological  differences do  exist.  Electro- 
phoretic mobilities and serologic data suggest that these differences in strepto- 
kinases may be somewhat analogous to the differences observed in the enzyme 
hybrids of the lactic dehydrogenase series of the developing chick (30). In this 
regard, it is of interest that the streptokinases,  like the lactic dehydrogenases, 
show  immunological  cross-reactions,  as  might be  anticipated in  a  series of 
hybrid molecules (30). This is in contrast to the streptococcal  desoxyribonu- 
cleases which do not show immunological  cross-reactions  and therefore  may 
not be true isozymes of the classical type. It is also of interest that most strains 
of Group A streptococci produce several different desoxyribonucleases, whereas HUGH  C.  DILLON  AND  LEWIS  W.  WANNAMAKER  369 
among the strains of Group A streptococci examined, each produces only one 
streptokinase. This characteristic in regard to streptokinase production facili- 
tates immunological screening since this can be readily done with crude super- 
nates. 
Further definition of the differences in streptokinases may be expedited by 
the isolation of streptokinases in a  more purified state. In addition, the de- 
velopment of a  system for assaying streptokinase directly would simplify the 
comparison of preparations from different strains. Such knowledge concerning 
streptokinase would also contribute to the understanding of whether strepto- 
kinase can be considered a  true enzyme rather  than an activator substance 
(31). 
SUMWrARY 
Two strains of Group A streptococci have been shown to produce strepto- 
kinases with different physical and immunologic characteristics. These strepto- 
kinases  have  been  designated  SK-A  and  SK-B.  Examination of additional 
strains of Group A streptococci has indicated that SK-A is the more commonly 
encountered streptokinase. 
Studies comparing the  two  Group A  streptokinases  with streptokinase  of 
Group  C  origin have indicated that the latter streptokinase is intermediate 
between SK-A and SK-B in regard to its electrophoretic mobility. Immuno- 
logical data suggest that the Group C streptokinase differs from SK-B but is 
closely related to SK-A. 
The authors acknowledge  with pleasure the valuable technical assistance of Mrs. JoAnn 
Nelson and Miss Barbara Hayes. 
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